Sputnik V Vaccine May Be Widely Used in Russia in Late October, RDIF CEO Says Press Service of the Ministry of Health of the Russian FederationRussia17:25 GMT 12.10.2020(updated 17:28 GMT 12.10.2020) Get short URL7334Subscribehttps://cdn1.img.sputniknews.com/img/07e4/08/11/1080192224_0:93:1200:768_1200x675_80_0_0_8eb8fca41aef4d12b858933124b31e52.jpgSputnik Internationalhttps://cdn2.img.sputniknews.com/i/logo.pngSputnikhttps://cdn2.img.sputniknews.com/i/logo.pnghttps://sputniknews.com/russia/202010121080750929-sputnik-v-vaccine-may-be-widely-used-in-russia-in-late-october-rdif-ceo-says/
MOSCOW (Sputnik) – Sputnik V vaccine may be widely used in Russia in late October-early November, Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev said on Monday.
“Of course, we also hope that it will be possible to approve and launch the Russian vaccine, including in the Middle East, as early as in November,” he added.
He noted that at the moment the Russian vaccine was the first in the world in terms of approval and interest of various countries. Earlier on Monday, the Ministry of Health and Prevention of the United Arab Emirates approved the conduct of phase III of clinical trials of Russian coronavirus vaccine Sputnik V in the country.